vimarsana.com

Page 4 - Raju Mohan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brokerages Set Ventyx Biosciences, Inc (NASDAQ:VTYX) Target Price at $31 13

Brokerages Set Ventyx Biosciences, Inc (NASDAQ:VTYX) Target Price at $31 13
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ventyx Biosciences, Inc (NASDAQ:VTYX) Receives Average Rating of Hold from Brokerages

Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) have received a consensus recommendation of “Hold” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month […]

Ventyx Biosciences Inc CEO Raju Mohan Sells 58,860 Shares

Raju Mohan, CEO and President of Ventyx Biosciences Inc, executed a sale of 58,860 shares in the company on December 20, 2023, according to a recent SEC Filing.

Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Ventyx Biosciences (NASDAQ:VTYX) Downgraded by Lifesci Capital

Lifesci Capital lowered shares of Ventyx Biosciences (NASDAQ:VTYX – Free Report) from an outperform rating to a market perform rating in a report published on Tuesday morning, PriceTargets.com reports. Lifesci Capital also issued estimates for Ventyx Biosciences’ Q4 2023 earnings at ($0.62) EPS and FY2023 earnings at ($2.93) EPS. VTYX has been the subject of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.